# Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

> **NCT00559026** · PHASE1 · COMPLETED · sponsor: **Istituto Superiore di Sanità** · enrollment: 10 (actual)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** Melan-A
- **OTHER:** Melan-A plus Dacarbazine

## Key facts

- **NCT ID:** NCT00559026
- **Lead sponsor:** Istituto Superiore di Sanità
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2007-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559026, "Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00559026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*